The invention
The use of novel antibodies against LANCL1 as a diagnostic and therapeutic target for the management and treatment of cancer
The invention
- Name of invention
- The use of novel antibodies against LANCL1 as a diagnostic and therapeutic target for the management and treatment of cancer
- Utilisation de nouveaux anticorps contre LANCL1 comme cible diagnostique et thérapeutique pour la gestion et le traitement du cancer
Invention description
- Description
- This invention is to use monoclonal antibodies to target the protein LANCL1 to treat liver cancer. Targeting LANCL1 protein on the cell surface of human liver tumor-initiating cells blocks the initiation and growth of liver tumors.
INVENTORS
Yu Man TSUI inventor 3727293067_3363
Irene Oi Lin Lui NG inventor 3727293067_3362
The University of Hong Kong inventor 3727293067_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.